Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural Modified Surfactant
- Development stage
- Unknown
- Lead developer
- Chiesi
- Administration
- Endotracheal Administration
01
Overview
Pulmonary surfactants are complex mixtures of phospholipids and proteins that reduce surface tension within the lungs, preventing alveolar collapse. Natural surfactants are derived from animal sources (e.g., bovine or porcine lungs) and may be modified through purification and extraction processes. These surfactants are primarily used to treat respiratory distress syndrome (RDS) in newborns.
- Brand names
- CurosurfSurvantaInfasurf
- Other names
- Natural surfactantanimal-derived surfactant
Beyond the preview
Go deeper on Natural Modified Surfactant.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Natural Modified Surfactant.